Analyst Ratings for Acorda Therapeutics, Inc. (ACOR)

ACOR Rating Summary

  |   Expand Research on ACOR
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 2.1 / 10   Percentile Rank: 15%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
6/17/2021 H.C. Wainwright Raghuram Selvaraju Upgrade Buy
(Neutral)		 10.00
(5.00)		 4.10
(0.66)		 -83.9% Details
10/24/2019 JPMorgan Cory Kasimov Downgrade Underweight
(Neutral)		 N/A
(N/A)		 2.42
(0.66)		 -72.73% Details